Shouyao Holdings (Beijing) Co. Ltd. A (SHG:688197) — Market Cap & Net Worth
Market Cap & Net Worth: Shouyao Holdings (Beijing) Co. Ltd. A (688197)
Shouyao Holdings (Beijing) Co. Ltd. A (SHG:688197) has a market capitalization of $850.47 Million (CN¥5.81 Billion) as of September 24, 2026. Listed on the SHG stock exchange, this China-based company holds position #9756 globally and #2547 in its home market, demonstrating a 19.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shouyao Holdings (Beijing) Co. Ltd. A's stock price CN¥39.08 by its total outstanding shares 148719343 (148.72 Million). Also see 688197 current and non-current assets for a full breakdown of the balance sheet.
Shouyao Holdings (Beijing) Co. Ltd. A Market Cap History: 2022 to 2026
Shouyao Holdings (Beijing) Co. Ltd. A's market capitalization history from 2022 to 2026. Data shows growth from $528.39 Million to $850.47 Million (4.46% CAGR). Also see 688197 cash flow conversion for how efficiently the company converts equity into cash flow.
Shouyao Holdings (Beijing) Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shouyao Holdings (Beijing) Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 688197 stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
87.22x
Shouyao Holdings (Beijing) Co. Ltd. A's market cap is 87.22 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $528.39 Million | $1.83 Million | -$173.82 Million | 289.18x | N/A |
| 2023 | $1.20 Billion | $5.23 Million | -$185.57 Million | 229.69x | N/A |
| 2024 | $649.39 Million | $3.94 Million | -$211.94 Million | 164.73x | N/A |
| 2025 | $756.02 Million | $8.67 Million | -$128.83 Million | 87.22x | N/A |
Competitor Companies of 688197 by Market Capitalization
Companies near Shouyao Holdings (Beijing) Co. Ltd. A in the global market cap rankings as of September 24, 2026. Review tangible equity quality of Shouyao Holdings (Beijing) Co. Ltd. A to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Shouyao Holdings (Beijing) Co. Ltd. A by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #187 globally with a market cap of $130.53 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #334 globally with a market cap of $80.46 Billion USD.
- CSL Ltd (AU:CSL): Ranked #451 globally with a market cap of $62.04 Billion USD ( AU$87.68 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #510 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #187 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.53 Billion | $514.99 |
| #334 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $80.46 Billion | $803.90 |
| #451 | CSL Ltd | AU:CSL | $62.04 Billion | AU$180.72 |
| #510 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $182.56 |
Shouyao Holdings (Beijing) Co. Ltd. A Historical Marketcap From 2022 to 2026
Between 2022 and today, Shouyao Holdings (Beijing) Co. Ltd. A's market cap moved from $528.39 Million to $ 850.47 Million, with a yearly change of 4.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥850.47 Million | +12.49% |
| 2025 | CN¥756.02 Million | +16.42% |
| 2024 | CN¥649.39 Million | -45.93% |
| 2023 | CN¥1.20 Billion | +127.31% |
| 2022 | CN¥528.39 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Shouyao Holdings (Beijing) Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $850.47 Million USD |
| MoneyControl | $850.47 Million USD |
| MarketWatch | $850.47 Million USD |
| marketcap.company | $850.47 Million USD |
| Reuters | $850.47 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shouyao Holdings (Beijing) Co. Ltd. A
Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of drugs in China. The company offers drugs for oncology indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China.